The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy.
 
Charles Charles Li
Employment - RenovoRx
Stock and Other Ownership Interests - RenovoRx
 
Amer H. Zureikat
No Relationships to Disclose
 
Paula M. Novelli
No Relationships to Disclose
 
Charles D. Lopez
Consulting or Advisory Role - Astellas Pharma; Boston Biomedical; Boston Scientific; Celgene; Exelixis; Pfizer
Research Funding - Taiho Pharmaceutical
Travel, Accommodations, Expenses - RenovoRx
 
Adel Kardosh
Consulting or Advisory Role - Exelixis; Exelixis
 
Ki Y. Chung
Consulting or Advisory Role - Genentech
Speakers' Bureau - Genentech
Research Funding - MedImmune (Inst)
 
Aron Michael Devane
No Relationships to Disclose
 
Hassan Hatoum
Consulting or Advisory Role - Foundation Medicine
 
Kenneth Lee Meredith
No Relationships to Disclose
 
Emmanuel E. Zervos
No Relationships to Disclose
 
Antonio Ucar
No Relationships to Disclose
 
Ripal T Gandhi
No Relationships to Disclose
 
Reza Nazemzadeh
Stock and Other Ownership Interests - Amgen; Constellation Pharmaceuticals; Exelixis; Johnson & Johnson
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - Foundation Medicine; Ipsen (Inst); Natera; Taiho Pharmaceutical (Inst)
Research Funding - Advanced Accelerator Applications (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Jochen Decaestecker
No Relationships to Disclose
 
Erik Vandestraeten
No Relationships to Disclose
 
Thierry Delaunoit
No Relationships to Disclose
 
Shahriar Sharif
Employment - RenovoRx
 
Ramtin Agah
Employment - RenovoRx
Leadership - RenovoRx
Stock and Other Ownership Interests - RenovoRx
Consulting or Advisory Role - RenovoRx
Patents, Royalties, Other Intellectual Property - RenovoRx
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Halozyme
Consulting or Advisory Role - ARMO BioSciences; AstraZeneca/MedImmune; Caris Life Sciences; Merck; Perthera; Rafael Pharmaceuticals; RenovoRx; Sirtex Medical
Research Funding - Abbvie (Inst); ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Curegenix (Inst); FibroGen (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm; Use patent for veliparib and FOLFOX
Travel, Accommodations, Expenses - Merck; Perthera; Sirtex Medical